Drug therapy: Treatment of pulmonary arterial hypertension

被引：1290

作者：

Humbert, M ^{[1
]}

Sitbon, O ^{[1
]}

Simonneau, G ^{[1
]}

机构：

[1] Univ Paris 11, Assistance Publ Hop Paris, Hop Antoine Beclere,Ctr Malad Vasc Pulm, Serv Pneumol & Reanimat Resp,Unite Propre Rech En, Clamart, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 14期

关键词：

D O I：

10.1056/NEJMra040291

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1425 / 1436

页数：12

共 97 条

[1] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension [J].

Aguilar, RV ;

Farber, HW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1846-1850

[2] Characterization of high-altitude pulmonary hypertension in the Kyrgyz: Association with angiotensin-converting enzyme genotype [J].

Aldashev, AA ;

Sarybaev, AS ;

Sydykov, AS ;

Kalmyrzaev, BB ;

Kim, EV ;

Mamanova, LB ;

Maripov, R ;

Kojonazarov, BK ;

Mirrakhimov, MM ;

Wilkins, MR ;

Morrell, NW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (10) :1396-1402

[3] Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial [J].

Badesch, DB ;

Tapson, VF ;

McGoon, MD ;

Brundage, BH ;

Rubin, LJ ;

Wigley, FM ;

Rich, S ;

Barst, RJ ;

Barrett, PS ;

Kral, KM ;

Jöbsis, MM ;

Loyd, JE ;

Murali, S ;

Frost, A ;

Girgis, R ;

Bourge, RC ;

Ralph, DD ;

Elliott, CG ;

Hill, NS ;

Langleben, D ;

Schilz, RJ ;

McLaughlin, VV ;

Robbins, IM ;

Groves, BM ;

Shapiro, S ;

Medsger, TA ;

Gaine, SP ;

Horn, E ;

Decker, JC ;

Knobil, K .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) :425-+

[4] Sitaxsentan therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

Langleben, D ;

Frost, A ;

Horn, EM ;

Oudiz, R ;

Shapiro, S ;

McLaughlin, V ;

Hill, N ;

Tapson, VF ;

Robbins, IM ;

Zwicke, D ;

Duncan, B ;

Dixon, RAF ;

Frumkin, LR .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447

[5] Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension - Open-label pilot study [J].

Barst, RJ ;

Rich, S ;

Widlitz, A ;

Horn, EM ;

McLaughlin, V ;

McFarlin, J .

CHEST, 2002, 121 (06) :1860-1868

[6] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[7] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[8] Endothelin antagonists [J].

Benigni, A ;

Remuzzi, G .

LANCET, 1999, 353 (9147) :133-138

[9] Immediate and long-term hemodynamic and clinical effects of Sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy [J].

Bhatia, S ;

Frantz, RP ;

Severson, CJ ;

Durst, LA ;

McGoon, MD .

MAYO CLINIC PROCEEDINGS, 2003, 78 (10) :1207-1213

[10] PRIMARY PULMONARY-HYPERTENSION - A HISTOPATHOLOGIC STUDY OF 80 CASES [J].

BJORNSSON, J ;

EDWARDS, WD .

MAYO CLINIC PROCEEDINGS, 1985, 60 (01) :16-25

← 1 2 3 4 5 6 7 8 9 10 →